The Nation’s First Psilocybin Facilitator Licenses Have Been Approved
by Destiny O.
1-833-663-7284 (Customer Support Available 24/7)
If you find yourself to be one of those individuals that like to make investments for the future, you may have thought about investing in cannabis stocks. This investment is considered risky by many analysts. This is because cannabis is still currently a federally illegal substance. Under federal law, cannabis is a scheduled one controlled substance with no medical value and a high addiction rate in the United States of America. Even though many states have gone against federal law and legalized cannabis, investing in this industry is still considered risky.
Many people have a hard time investing hard-earned money into an industry that can’t even legally work with most banks. This doesn’t mean that cannabis stocks haven’t been a hot ticket for investors looking for a big payday. Some of those who invested in the cannabis industry have found success while others found themselves not so lucky. Years ago, the cannabis startup MassRoots seemed like it would be a no-brainer to add to any portfolio if you were considering purchasing stock in the cannabis industry. However, that quickly changed as the company ended up tanking out.
A lot of people turned to investing in companies like Canopy Growth and Aphria when it came to surefire investments for their stock portfolio. Some of these investments have panned out to be successful, and others not so much. When it comes to making investments in cannabis stocks, there’s not much time left if you’re looking to get in on the big payday. Investors who took the risk are the ones that will reap the biggest reward. Once the investment of purchasing a cannabis stock becomes a safe action, the potential earnings from the stocks will decrease substantially. That doesn’t mean that you can’t get in on a great investment when it comes to plant-based medicine.
If you feel like you’ve missed the boat on investing with cannabis, a relatively new stock area that may be of interest to you would be investing in medicinal psychedelics. Medicinal psychedelics have technically been around for quite a while. More recently, the news of potentially treating depression and anxiety using psilocybin mushrooms has made its way into the news. The state of Oregon voted to legalize medicinal psilocybin, becoming the first in the nation to pass such a law. Residents in Oregon can be recommended medicinal mushrooms as a patient, much like the way a physician can recommend medical cannabis to a patient. Additionally, magic mushrooms are quickly becoming increasingly more acceptable in the United States. They have been decriminalized in Denver, Colorado, legalized in the state of Oregon, and they are also decriminalized in our nation’s capital Washington D.C. This is going to become a growing industry, much like cannabis. In my opinion, you will start to see psilocybin legalization laws pop up in other states across the nation over the next few years. Plant-based medicine can be remarkably effective. In a time when medications and prescriptions come with so many dangerous and deadly side effects, many people are looking to get back to their roots.
Whether it be recreational or medicinal, investments in the industries of cannabis and psilocybin mushrooms are going to continue to cultivate success with investors. Canopy Growth Corp, Tilray, and Cronos Group Inc. were some of the top cannabis stocks of 2020. Some of the best value in cannabis stocks were considered to be Organigram Holdings Inc., Harvest Health and Recreation Inc., and Amyris Inc. Among some of the fastest-growing cannabis stocks, you’ll find 4front Ventures Corp., Jushi Holdings Inc., and Cresco Labs Inc.
When it comes to the magical world of psilocybin mushrooms and psychedelic-based medicines, there are two stocks making waves with investors that many are hopping on to hoping to surf out into financial security. Champion Brands is a Vancouver based company accelerating rapidly in the field of psychedelic medicine. They announced they would make the acquisition of AltMed Capital Corp in April of this year. Champion Brands is another company that has plans to open clinics for psychedelic medicine such as MDMA, ketamine, and psilocybin throughout North America. Mind Medicine is considered one of the biggest biotechs in the field of therapeutic psychedelics. Mind Medicine saw great success with its Compass Pathways IPO and is currently in the process of enlisting with the U.S. stock exchange. This gives great potential to investors staying up on current trends. Mind Medicine has current studies establishing the effectiveness of LSD in helping neurological issues. The company is not a basement startup. It already has an estimated 23.7 million in total assets. Financial stability like this will definitely help pave the path for future generational success.
Now you are armed with some knowledge about cannabis as well as psychedelic stocks. You can use this knowledge as a great conversation piece or in your arsenal for making investments in your future. A small investment in cannabis and psychedelic stocks today could bring the blazing success that might leave you tripping over the profit you make.
According to research, “Migraine is highly prevalent, affecting 12% of the population, attacking up to 17% of women and 6% of men yearly. Among children, it tends to happen more in girls than boys.” A migraine can be very disabling and last from hours to two or three days. Migraines are considered to be the…
PTSD can have far-reaching effects on health, functionality as well as on quality of living, which is why having access to effective treatment is so important. If you are living with PTSD or are living with someone who has PTSD, you would have first-hand experience with how challenging it can be getting through life on…
Up until recently, lack of cannabis education meant that people were blissfully unaware of the fact that the plant is not limited to just one strain and, therefore, does not produce just one type of effect. Fortunately, agricultural experimentation has led to the market exploding in terms of strains that can satisfy everyone, from beginners…
Using cannabis to help combat anxiety is a tricky business. Studies have given us significant evidence that cannabis can be used to help cope with anxiety and because anxiety is so common, that’s an extremely welcome piece of information. In fact, 72% of daily cannabis users reported consumption to relax or relieve tension and 58%…
A cannabis compound that has been described as “cutting-edge” and “so elusive, laboratories often misidentify the compound as CBC (cannabichromene) or CBL (cannabicyclol)” is finally becoming better understood. Delta-10-tetrahydrocannabinol (delta-10 THC) is a need-to-know cannabinoid, and here’s why. What Is Delta-10 THC? Does Delta-10 Get You High? Is Delta-10 Safe? How Is Delta-10 Created? Is…
The anti-nausea and vomiting effects of cannabis have been known for several centuries. The evidence eventually became so compelling in clinical trials…
Experts are taking a bird’s eye view of an exciting and rapidly evolving area in cannabis research known as the endocannabinoidome (eCBome)….
Spliffs and joints, while similar, are different cannabis products rolled up in paper. If you are a seasoned cannabis smoker, you’re probably…
